Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3077 |
|
Actual shortage: | 235 (8%) | |
Anticipated shortage: | 16 (1%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2817 (92%) | |
Discontinuation Reports |
356 |
|
To be discontinued: | 22 (6%) | |
Discontinued: | 334 (94%) | |
Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
31 (11%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-NAPRO-NA | 275MG | TABLET | Resolved | 2022-06-06 | 2022-08-22 | 162077 |
APO-NAPRO-NA DS | 550MG | TABLET | Resolved | 2019-01-03 | 2019-02-08 | 71139 |
APO-NAPRO-NA DS | 550MG | TABLET | Resolved | 2022-07-15 | 2022-08-24 | 164744 |
APO-NAPRO-NA DS | 550MG | TABLET | Resolved | 2023-05-26 | 2023-07-27 | 193215 |
APO-NAPRO-NA DS | 550MG | TABLET | Resolved | 2017-05-24 | 2018-10-05 | 11082 |
APO-NAPROXEN | 500MG | TABLET | Resolved | 2017-10-03 | 2018-03-01 | 24274 |
APO-NAPROXEN | 250MG | TABLET | Resolved | 2018-02-01 | 2018-04-05 | 37971 |
APO-NAPROXEN | 375MG | TABLET | Resolved | 2018-02-26 | 2018-07-18 | 41142 |
APO-NAPROXEN | 500MG | TABLET | Resolved | 2018-03-27 | 2018-04-10 | 44111 |
APO-NAPROXEN | 500MG | TABLET | Resolved | 2018-05-31 | 2018-08-14 | 50961 |
APO-NAPROXEN | 250MG | TABLET | Resolved | 2018-08-09 | 2018-10-26 | 57799 |
APO-NAPROXEN | 375MG | TABLET | Resolved | 2018-11-30 | 2018-12-21 | 68228 |
APO-NAPROXEN | 500MG | TABLET | Resolved | 2018-11-30 | 2019-05-24 | 68231 |
APO-NAPROXEN | 250MG | TABLET | Resolved | 2018-12-12 | 2018-12-21 | 69305 |
APO-NAPROXEN | 375MG | TABLET | Resolved | 2018-12-12 | 2018-12-21 | 69312 |
APO-NAPROXEN | 500MG | TABLET | Resolved | 2018-12-12 | 2018-12-27 | 69315 |
APO-NAPROXEN | 500MG | TABLET | Resolved | 2019-03-13 | 2019-05-13 | 78536 |
APO-NAPROXEN | 500MG | TABLET | Resolved | 2019-03-13 | 2019-05-13 | 78541 |
APO-NAPROXEN | 375MG | TABLET | Resolved | 2020-01-22 | 2020-02-21 | 103914 |
APO-NAPROXEN | 375MG | TABLET | Resolved | 2020-02-05 | 2020-02-21 | 105352 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-TOLTERODINE | 1MG | TABLET | Discontinued | 2018-09-08 | 2019-01-17 | 60822 |
APO-TOLTERODINE | 2MG | TABLET | Discontinued | 2018-09-08 | 2018-11-09 | 60825 |
APO-TOLTERODINE | 2MG | TABLET | Discontinued | 2018-09-08 | 2019-06-12 | 60828 |
APO-TRAZODONE TABLETS 100MG | 100MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60831 |
APO-TRAZODONE TABLETS 50MG | 50MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60834 |
APO-VALACYCLOVIR | 500MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60840 |
APO-VALGANCICLOVIR | 450MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60843 |
APO-VALPROIC ACID ORAL SOLUTION | 250MG | SOLUTION | Discontinued | 2023-09-26 | 2023-11-02 | 205310 |
APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71029 | ||
APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71032 | ||
APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71035 | ||
APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71038 | ||
APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71044 | ||
APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71048 | ||
APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71051 | ||
APO-VALSARTAN/HCTZ | 12.5MG 160MG | TABLET | Discontinued | 2019-01-03 | 2019-01-03 | 71054 |
APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71057 | ||
APO-VORICONAZOLE | 200MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60858 |
APO-VORICONAZOLE | 50MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60861 |
APO-ZOLMITRIPTAN | 2.5MG | TABLET | Discontinued | 2018-02-26 | 2018-02-26 | 40960 |